Intestinal stem cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for ...
In the EPCORE DLBCL-3 study, fixed-duration epcoritamab monotherapy delivered deep, durable responses with manageable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback